These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Peripheral applications of drug-coated balloons: past, present and future. Krokidis M; Spiliopoulos S; Katsanos K; Sabharwal T Cardiovasc Intervent Radiol; 2013 Apr; 36(2):281-91. PubMed ID: 22915325 [TBL] [Abstract][Full Text] [Related]
13. Standards of practice for superficial femoral and popliteal artery angioplasty and stenting. Katsanos K; Tepe G; Tsetis D; Fanelli F Cardiovasc Intervent Radiol; 2014 Jun; 37(3):592-603. PubMed ID: 24722891 [TBL] [Abstract][Full Text] [Related]
14. Advances in below-the-knee drug-eluting balloons. Ferraresi R; Centola M; Biondi-Zoccai G J Cardiovasc Surg (Torino); 2012 Apr; 53(2):205-13. PubMed ID: 22456643 [TBL] [Abstract][Full Text] [Related]
15. Sirolimus-eluting stents for treatment of infrapopliteal arteries reduce clinical event rate compared to bare-metal stents: long-term results from a randomized trial. Rastan A; Brechtel K; Krankenberg H; Zahorsky R; Tepe G; Noory E; Schwarzwälder U; Macharzina R; Schwarz T; Bürgelin K; Sixt S; Tübler T; Neumann FJ; Zeller T J Am Coll Cardiol; 2012 Aug; 60(7):587-91. PubMed ID: 22878166 [TBL] [Abstract][Full Text] [Related]
16. Endovascular interventions for infrapopliteal arterial disease: an update. Rana MA; Gloviczki P Semin Vasc Surg; 2012 Mar; 25(1):29-34. PubMed ID: 22595479 [TBL] [Abstract][Full Text] [Related]
17. Drug-coated balloons for infrapopliteal disease: digging deep to understand the impact of a negative trial. Laird JR; Armstrong EJ J Am Coll Cardiol; 2014 Oct; 64(15):1577-9. PubMed ID: 25301460 [No Abstract] [Full Text] [Related]